Ivannikova et al. [22] provided evidence of a significant two-fold increase in b-FGF in patients dealing with coronary heart disease (CHD), type 2 diabetes mellitus (T2DM), and acute coronary syndrome (ACS) in comparison to healthy people [22]; see Table 4. This evidence concerns the gene FGF2 and coronary artery disorder.